Matches in Wikidata for { <http://www.wikidata.org/entity/Q64643997> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q64643997 description "clinical trial" @default.
- Q64643997 description "ensayu clínicu" @default.
- Q64643997 description "klinisch onderzoek" @default.
- Q64643997 description "клінічне випробування" @default.
- Q64643997 name "A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin" @default.
- Q64643997 type Item @default.
- Q64643997 label "A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin" @default.
- Q64643997 prefLabel "A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin" @default.
- Q64643997 P1132 Q64643997-50BFBBAC-2CBE-4166-8BB5-5614A82826AB @default.
- Q64643997 P131 Q64643997-EB36FF28-A0F4-4FD5-AA1E-307DC4ADEE35 @default.
- Q64643997 P1476 Q64643997-A612FB64-3DBF-4ADB-B45D-FE559DFBAD3A @default.
- Q64643997 P17 Q64643997-DA1A6FB5-96F6-42B0-BFD4-034826C51F8E @default.
- Q64643997 P1813 Q64643997-9CFAC762-B91B-4DEF-B5A3-450FAC1EAB60 @default.
- Q64643997 P2283 Q64643997-6FDEA38C-D711-422A-AA59-3465F8A0A8B7 @default.
- Q64643997 P2899 Q64643997-90616A96-1B85-4BE8-B12E-60DDF06C8E0B @default.
- Q64643997 P3098 Q64643997-04D138EE-71D1-4E4A-AE95-5E04EEF236CF @default.
- Q64643997 P31 Q64643997-90A685AC-1232-4A9C-9530-60BB99298AD6 @default.
- Q64643997 P4135 Q64643997-805F7DA6-857A-4851-A6F7-77AAAD07328D @default.
- Q64643997 P4844 Q64643997-DDCAC3B4-8C6E-40D6-A9D3-F6FD8B4AFFD0 @default.
- Q64643997 P580 Q64643997-45817DEA-4F16-40B9-8E59-A071B1138531 @default.
- Q64643997 P582 Q64643997-C80F2832-BCDE-4529-B21A-4CC1EE87841B @default.
- Q64643997 P6099 Q64643997-FFD78646-1AE0-4CC5-891E-3D4C707F0182 @default.
- Q64643997 P6153 Q64643997-08045E00-1F37-4F58-9173-319F31293B01 @default.
- Q64643997 P6153 Q64643997-E7B01CA1-41F1-4368-849E-53AE8A1896FC @default.
- Q64643997 P8363 Q64643997-3111671D-A47E-4F66-8957-09BDCFE8741B @default.
- Q64643997 P859 Q64643997-18AAD65C-4E41-45A2-9A45-D9ABEB563AAF @default.
- Q64643997 P1132 "+406" @default.
- Q64643997 P131 Q1183 @default.
- Q64643997 P1476 "A Phase III, Open-label, Multicenter, Long-term Safety Study Of Intravenous Epoetin Hospira In Patients With Chronic Renal Failure Requiring Hemodialysis And Receiving Epoetin Maintenance Treatment" @default.
- Q64643997 P17 Q30 @default.
- Q64643997 P1813 "AiME - 03" @default.
- Q64643997 P2283 Q1755136 @default.
- Q64643997 P2899 "+18" @default.
- Q64643997 P3098 "NCT01628107" @default.
- Q64643997 P31 Q30612 @default.
- Q64643997 P4135 "+80" @default.
- Q64643997 P4844 Q5383794 @default.
- Q64643997 P580 "2012-07-16T00:00:00Z" @default.
- Q64643997 P582 "2015-01-02T00:00:00Z" @default.
- Q64643997 P6099 Q42824827 @default.
- Q64643997 P6153 Q1277776 @default.
- Q64643997 P6153 Q30269596 @default.
- Q64643997 P8363 Q78089383 @default.
- Q64643997 P859 Q206921 @default.